Key result
A family of 4 members presented with Carney's complex, characterized by recurrent atrial myxomas and PRKAR1α gene mutations, requiring vigorous multiorgan screening.
Case Report (n=4)
Highlights the clinical presentation and genetic basis of Carney's complex, emphasizing the need for comprehensive screening in affected families.
Answers are grounded in this paper and cite their sources.
May support family screening in Carney complex; leaves open standardized protocols pending larger cohorts.
We report on a family of 4 members, all of whom have had multifocal, recurrent atrial myxomas associated with skin pigmentation, melanotic schwannomas, mucocutaneous myxomas, and tumors of the ovary and pituitary, adrenal, and thyroid glands. Immunochemistry of the myxoma cells is positive for calretinin, confirming their neuroendocrine origin. Genetic studies confirmed mutations in the gene coding protein kinase A, regulatory subunit 1-α (PRKAR1α). This is Carney's complex, characterized by multiple, mucocutaneous myxomas; pigmented lesions over the lips, conjunctiva, and genitalia; adenomas of the breast and thyroid; schwannomas; and endocrinal abnormalities including Cushing syndrome and acromegaly. Members of the family require vigorous screening, including urinary free cortisol, plasma transforming growth factor-β(1) and thyrotropin-releasing hormone, testicular ultrasound, routine echocardiographic screening, searches for cardiac and mucocutaneous myxomas in multiple locations, and genetic studies for the PRKAR1α gene sequence.
No takes yet. Share an insight, caveat, or question.
Roy et al. (2011) conducted a case report in Carney's Complex (n=4). PRKAR1α gene mutation was evaluated. A family of 4 members presented with Carney's complex, characterized by recurrent atrial myxomas and PRKAR1α gene mutations, requiring vigorous multiorgan screening.
Synapse has enriched 10 related papers. Consider them for comparative context: